Investigation on factors related to uterine fibroids in rural women of northern Anhui province
暂无分享,去创建一个
[1] Alistair R W Williams,et al. Physiology of the endometrium and regulation of menstruation. , 2020, Physiological reviews.
[2] M. Yano,et al. Encyclopedia of endometriosis: a pictorial rad-path review , 2020, Abdominal Radiology.
[3] Y. Jayasinghe,et al. Exploring the unmet needs of parents of adolescent girls with heavy menstrual bleeding and dysmenorrhea: a qualitative study. , 2019, Journal of pediatric and adolescent gynecology.
[4] Mohammed A. K. Mahdy,et al. Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana’a city, Yemen , 2019, BMC Infectious Diseases.
[5] Yan Tang,et al. A quantitative analysis infection of ovarian cyst based on examination data of computed tomography and type-B ultrasonography. , 2019, Journal of infection and public health.
[6] Advaita Punjala-Patel,et al. Hypothalamic-Pituitary-Ovarian Axis Disorders Impacting Female Fertility , 2019, Biomedicines.
[7] D. Leavesley,et al. Menstrual fluid factors facilitate tissue repair: identification and functional action in endometrial and skin repair , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] P. Carmeliet,et al. Hypoxia and hypoxia inducible factor-1α are required for normal endometrial repair during menstruation , 2018, Nature Communications.
[9] D. Baird,et al. Self-reported bacterial vaginosis and risk of ultrasound-diagnosed incident uterine fibroid cases in a prospective cohort study of young African American women. , 2017, Annals of epidemiology.
[10] D. Friend. Drug delivery for the treatment of endometriosis and uterine fibroids , 2017, Drug Delivery and Translational Research.
[11] F. Nezhat,et al. Strong Association Between Endometriosis and Symptomatic Leiomyomas , 2016, JSLS : Journal of the Society of Laparoendoscopic Surgeons.
[12] C. Mehedințu,et al. Endometriosis still a challenge , 2014, Journal of medicine and life.
[13] Md Soriful Islam,et al. Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction , 2013, Obstetrics and gynecology international.
[14] D. Baird,et al. Association of age at menarche with increasing number of fibroids in a cohort of women who underwent standardized ultrasound assessment. , 2013, American journal of epidemiology.
[15] H. Yoo,et al. Control of puberty: genetics, endocrinology, and environment , 2013, Current opinion in endocrinology, diabetes, and obesity.
[16] J. Kim,et al. The role of progesterone signaling in the pathogenesis of uterine leiomyoma , 2012, Molecular and Cellular Endocrinology.
[17] M. He,et al. Evaluation of 14-3-3 protein family levels and associated receptor expression of estrogen and progesterone in Human Uterine Leiomyomas , 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[18] David Bernuit,et al. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women , 2012, BMC Women's Health.
[19] R. Aryeetey,et al. Age of menarche among basic level school girls in Medina, Accra. , 2011, African journal of reproductive health.
[20] C. Walker. Epigenomic reprogramming of the developing reproductive tract and disease susceptibility in adulthood. , 2011, Birth defects research. Part A, Clinical and molecular teratology.
[21] D. Esserman,et al. The association between self-reported major life events and the presence of uterine fibroids. , 2010, Women's health issues : official publication of the Jacobs Institute of Women's Health.
[22] Ye-huan Sun,et al. Risk factors for reproductive tract infections among married women in rural areas of Anhui Province, China. , 2009, European journal of obstetrics, gynecology, and reproductive biology.
[23] S. Okolo. Incidence, aetiology and epidemiology of uterine fibroids. , 2008, Best practice & research. Clinical obstetrics & gynaecology.
[24] E. Peterson,et al. Uterine Artery Embolization for Treatment of Leiomyomata: Long-Term Outcomes From the FIBROID Registry , 2008, Obstetrics and gynecology.
[25] J. Palmer,et al. Perceived Racial Discrimination and Risk of Uterine Leiomyomata , 2007, Epidemiology.
[26] K. Lohr,et al. Management of uterine fibroids: an update of the evidence. , 2007, Evidence report/technology assessment.
[27] Idhaliz Flores,et al. Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease. , 2007, Fertility and sterility.
[28] E. Susman,et al. Family composition and menarcheal age: Anti‐inbreeding strategies , 2006, American journal of human biology : the official journal of the Human Biology Council.
[29] H. Hatasaka. The evaluation of abnormal uterine bleeding. , 2005, Clinical obstetrics and gynecology.
[30] P. Neven,et al. Endometriosis and the development of malignant tumours of the pelvis. A review of literature. , 2004, Best practice & research. Clinical obstetrics & gynaecology.
[31] D. Spiegelman,et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. , 2004, American journal of epidemiology.
[32] J. Toppari,et al. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. , 2003, Endocrine reviews.
[33] B. Green,et al. The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[34] Irva Hertz-Picciotto,et al. Self‐Reported Heavy Bleeding Associated With Uterine Leiomyomata , 2003, Obstetrics and gynecology.
[35] D. Dunson,et al. Why is Parity Protective for Uterine Fibroids? , 2003, Epidemiology.
[36] B. Green,et al. The CYP 3 A 4 * 1 B Variant Is Related to the Onset of Puberty , A Known Risk Factor for the Development of Breast Cancer 1 , 2003 .
[37] M. Szklo,et al. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. , 2001, American journal of epidemiology.
[38] D. Baird,et al. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. , 2000, Environmental health perspectives.
[39] K. Hirschhorn,et al. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. , 2000, Cancer genetics and cytogenetics.
[40] J. Manson,et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. , 1998, Fertility and sterility.
[41] J. Manson,et al. Variation in the Incidence of Uterine Leiomyoma Among Premenopausal Women by Age and Race , 1997, Obstetrics and gynecology.
[42] C. Hart,et al. Reproductive tract infections and abortion among adolescent girls in rural Nigeria , 1995, The Lancet.
[43] R. Barbieri,et al. Progesterone: A critical role in the pathogenesis of uterine myomas , 1995, American journal of obstetrics and gynecology.
[44] D. Apter,et al. Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. , 1983, The Journal of clinical endocrinology and metabolism.
[45] B. Macmahon,et al. Age at menarche, urine estrogens and breast cancer risk , 1982, International journal of cancer.